Loading…

Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture

The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with...

Full description

Saved in:
Bibliographic Details
Published in:Glycobiology (Oxford) 2002-05, Vol.12 (5), p.345-351
Main Authors: Yabushita, Hiromitsu, Noguchi, Yasuyuki, Habuchi, Hiroko, Ashikari, Satoko, Nakabe, Ken, Fujita, Masaru, Noguchi, Masayoshi, Esko, Jeffrey D., Kimata, Koji
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3
cites cdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3
container_end_page 351
container_issue 5
container_start_page 345
container_title Glycobiology (Oxford)
container_volume 12
creator Yabushita, Hiromitsu
Noguchi, Yasuyuki
Habuchi, Hiroko
Ashikari, Satoko
Nakabe, Ken
Fujita, Masaru
Noguchi, Masayoshi
Esko, Jeffrey D.
Kimata, Koji
description The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection.
doi_str_mv 10.1093/glycob/12.5.345
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71832019</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71832019</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</originalsourceid><addsrcrecordid>eNqF0c2LEzEYBvAgiltXz94kePA2bd5kkkyPUldXKMjCiuIlZDJvbHZnJjWZke1_b0qLgpc95fD-8uTjIeQ1sCWwtVj97A8utivgS7kUtXxCFlArVvGai6dkwdZyXSklmwvyIuc7xkBBI5-TC-BMM6b1guQr79FNmUZP3Q6H4GzfH-gQu-ADdnSHe5vCSONIN7veDocuWDol63ZxsFPINGOKv22iW07DeIwKhZYwnO9tOsQpOOqw73OZUjf305zwJXnmbZ_x1Xm9JF8_Xt1urqvtl0-fN--3lasFmyrhHdbgUHVd3anWKtUooZnSHUeH3mvvFbMeZCMcCg2ubaUV6DXnYJVHcUnenXL3Kf6aMU9mCPl4GTtinLPR0AjOYP0o5Kyuy-miwLf_wbs4p7E8wnBggkHDoKDVCbkUc07ozT6FoXyGAWaOrZlTawa4kaa0Vna8OcfO7YDdP3-uqYDqBEKe8OHv3KZ7o7TQ0lx__2FuPvBvaivBSPEHKFulLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>210301801</pqid></control><display><type>article</type><title>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</title><source>Oxford Journals Online</source><creator>Yabushita, Hiromitsu ; Noguchi, Yasuyuki ; Habuchi, Hiroko ; Ashikari, Satoko ; Nakabe, Ken ; Fujita, Masaru ; Noguchi, Masayoshi ; Esko, Jeffrey D. ; Kimata, Koji</creator><creatorcontrib>Yabushita, Hiromitsu ; Noguchi, Yasuyuki ; Habuchi, Hiroko ; Ashikari, Satoko ; Nakabe, Ken ; Fujita, Masaru ; Noguchi, Masayoshi ; Esko, Jeffrey D. ; Kimata, Koji</creatorcontrib><description>The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection.</description><identifier>ISSN: 0959-6658</identifier><identifier>EISSN: 1460-2423</identifier><identifier>DOI: 10.1093/glycob/12.5.345</identifier><identifier>PMID: 12070077</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Animals ; Chlamydia trachomatis ; Chlamydia trachomatis - drug effects ; Chlamydia trachomatis - pathogenicity ; CHO Cells ; Cricetinae ; HeLa Cells ; Heparan Sulfate Proteoglycans - physiology ; Heparin - pharmacology ; Heparin Lyase - pharmacology ; Humans ; Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans</subject><ispartof>Glycobiology (Oxford), 2002-05, Vol.12 (5), p.345-351</ispartof><rights>Copyright Oxford University Press(England) May 1, 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</citedby><cites>FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12070077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yabushita, Hiromitsu</creatorcontrib><creatorcontrib>Noguchi, Yasuyuki</creatorcontrib><creatorcontrib>Habuchi, Hiroko</creatorcontrib><creatorcontrib>Ashikari, Satoko</creatorcontrib><creatorcontrib>Nakabe, Ken</creatorcontrib><creatorcontrib>Fujita, Masaru</creatorcontrib><creatorcontrib>Noguchi, Masayoshi</creatorcontrib><creatorcontrib>Esko, Jeffrey D.</creatorcontrib><creatorcontrib>Kimata, Koji</creatorcontrib><title>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</title><title>Glycobiology (Oxford)</title><addtitle>Glycobiology</addtitle><description>The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection.</description><subject>Animals</subject><subject>Chlamydia trachomatis</subject><subject>Chlamydia trachomatis - drug effects</subject><subject>Chlamydia trachomatis - pathogenicity</subject><subject>CHO Cells</subject><subject>Cricetinae</subject><subject>HeLa Cells</subject><subject>Heparan Sulfate Proteoglycans - physiology</subject><subject>Heparin - pharmacology</subject><subject>Heparin Lyase - pharmacology</subject><subject>Humans</subject><subject>Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans</subject><issn>0959-6658</issn><issn>1460-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqF0c2LEzEYBvAgiltXz94kePA2bd5kkkyPUldXKMjCiuIlZDJvbHZnJjWZke1_b0qLgpc95fD-8uTjIeQ1sCWwtVj97A8utivgS7kUtXxCFlArVvGai6dkwdZyXSklmwvyIuc7xkBBI5-TC-BMM6b1guQr79FNmUZP3Q6H4GzfH-gQu-ADdnSHe5vCSONIN7veDocuWDol63ZxsFPINGOKv22iW07DeIwKhZYwnO9tOsQpOOqw73OZUjf305zwJXnmbZ_x1Xm9JF8_Xt1urqvtl0-fN--3lasFmyrhHdbgUHVd3anWKtUooZnSHUeH3mvvFbMeZCMcCg2ubaUV6DXnYJVHcUnenXL3Kf6aMU9mCPl4GTtinLPR0AjOYP0o5Kyuy-miwLf_wbs4p7E8wnBggkHDoKDVCbkUc07ozT6FoXyGAWaOrZlTawa4kaa0Vna8OcfO7YDdP3-uqYDqBEKe8OHv3KZ7o7TQ0lx__2FuPvBvaivBSPEHKFulLA</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>Yabushita, Hiromitsu</creator><creator>Noguchi, Yasuyuki</creator><creator>Habuchi, Hiroko</creator><creator>Ashikari, Satoko</creator><creator>Nakabe, Ken</creator><creator>Fujita, Masaru</creator><creator>Noguchi, Masayoshi</creator><creator>Esko, Jeffrey D.</creator><creator>Kimata, Koji</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20020501</creationdate><title>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</title><author>Yabushita, Hiromitsu ; Noguchi, Yasuyuki ; Habuchi, Hiroko ; Ashikari, Satoko ; Nakabe, Ken ; Fujita, Masaru ; Noguchi, Masayoshi ; Esko, Jeffrey D. ; Kimata, Koji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Chlamydia trachomatis</topic><topic>Chlamydia trachomatis - drug effects</topic><topic>Chlamydia trachomatis - pathogenicity</topic><topic>CHO Cells</topic><topic>Cricetinae</topic><topic>HeLa Cells</topic><topic>Heparan Sulfate Proteoglycans - physiology</topic><topic>Heparin - pharmacology</topic><topic>Heparin Lyase - pharmacology</topic><topic>Humans</topic><topic>Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yabushita, Hiromitsu</creatorcontrib><creatorcontrib>Noguchi, Yasuyuki</creatorcontrib><creatorcontrib>Habuchi, Hiroko</creatorcontrib><creatorcontrib>Ashikari, Satoko</creatorcontrib><creatorcontrib>Nakabe, Ken</creatorcontrib><creatorcontrib>Fujita, Masaru</creatorcontrib><creatorcontrib>Noguchi, Masayoshi</creatorcontrib><creatorcontrib>Esko, Jeffrey D.</creatorcontrib><creatorcontrib>Kimata, Koji</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Glycobiology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yabushita, Hiromitsu</au><au>Noguchi, Yasuyuki</au><au>Habuchi, Hiroko</au><au>Ashikari, Satoko</au><au>Nakabe, Ken</au><au>Fujita, Masaru</au><au>Noguchi, Masayoshi</au><au>Esko, Jeffrey D.</au><au>Kimata, Koji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture</atitle><jtitle>Glycobiology (Oxford)</jtitle><addtitle>Glycobiology</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>12</volume><issue>5</issue><spage>345</spage><epage>351</epage><pages>345-351</pages><issn>0959-6658</issn><eissn>1460-2423</eissn><abstract>The mechanism and inhibitors of Chlamydia trachomatis serovar L2 infection of eukaryotic host cells were studied using a tissue culture model infection system. Potent inhibition of infectivity was observed when elementary bodies (EBs) were exposed to heparin or when HeLa 229 cells were treated with heparinase. No significant inhibition was seen the other way around. The same potent inhibition was observed when EBs were exposed to chemically 2-O-desulfated heparin (2-ODS heparin), which is composed of repeating disaccharide units of IdoA-GlcNS(6S), but not when exposed to chemically 6-ODS heparin or completely desulfated and N-resulfated heparin, which is composed of repeating disaccharide units of IdoA(2S)-GlcNS or IdoA-GlcNS, respectively. The inhibitory effects of 2-ODS heparin could be seen only with oligosaccharides longer than dodecasaccharides. The mutant Chinese hamster ovary (CHO) cell line 677, which is deficient in the biosynthesis of heparan sulfate, was less sensitive to C. trachomatis infection than were wild-type CHO cells. F-17 cells, deficient in 2-O-sulfation of heparan sulfate, had the same sensitivity to infection as wild-type CHO cells did. These data suggest that infection of host cells by EBS results from the specific binding of ligand molecules with affinity for heparin on the EB surface to heparan sulfate proteoglycans on the host cell surface. This binding may depend on host cell heparan sulfate chains that are 6-O-sulfated and longer than dodecasaccharides. The 2-ODS heparin oligosaccharides may be a potential agent for the prevention of C. trachomatis infection.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>12070077</pmid><doi>10.1093/glycob/12.5.345</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-6658
ispartof Glycobiology (Oxford), 2002-05, Vol.12 (5), p.345-351
issn 0959-6658
1460-2423
language eng
recordid cdi_proquest_miscellaneous_71832019
source Oxford Journals Online
subjects Animals
Chlamydia trachomatis
Chlamydia trachomatis - drug effects
Chlamydia trachomatis - pathogenicity
CHO Cells
Cricetinae
HeLa Cells
Heparan Sulfate Proteoglycans - physiology
Heparin - pharmacology
Heparin Lyase - pharmacology
Humans
Key words: chemically modified heparin/chlamydial attachment/heparan sulfate/heparinase/proteoglycans
title Effects of chemically modified heparin on Chlamydia trachomatis serovar L2 infection of eukaryotic cells in culture
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T05%3A27%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20chemically%20modified%20heparin%20on%20Chlamydia%20trachomatis%20serovar%20L2%20infection%20of%20eukaryotic%20cells%20in%20culture&rft.jtitle=Glycobiology%20(Oxford)&rft.au=Yabushita,%20Hiromitsu&rft.date=2002-05-01&rft.volume=12&rft.issue=5&rft.spage=345&rft.epage=351&rft.pages=345-351&rft.issn=0959-6658&rft.eissn=1460-2423&rft_id=info:doi/10.1093/glycob/12.5.345&rft_dat=%3Cproquest_cross%3E71832019%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c430t-3fce41ce6dd4d6ba668637067d2eceff7ff60af1583ce371cbb5a3ef7221a6fe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=210301801&rft_id=info:pmid/12070077&rfr_iscdi=true